S&P 500

5.346,99

-0,11%

Negocie como um profissional: Aproveite discussões em tempo real e ideias que movimentam o mercado para superar a concorrência.

Cadastre-se

Início
Investir
Ações
Canadá
TSXV
Pharmagap Inc. (GAP)
Pharmagap Inc. (GAP) Notícias

GAP

Pharmagap Inc. (GAP)

Pharmagap Inc.

De:

Notícias regulamentadas

Procure um Texto:

Ordenação:

Notícias não regulamentadas

Apresentando as notícias mais relevantes sobre:TSXV:GAP

1 2 3 Próxima >>

Data	Hora	Fonte	Título	Código	Companhia
07/05/2013	11:26	PR Newswire (Canada)	PharmaGap Notified of Cease Trade Order	TSXV:GAP	Pharmagap Inc.
06/05/2013	15:47	PR Newswire (Canada)	TSX Venture Exchange Cease Trade Order	TSXV:GAP	Pharmagap Inc.
06/05/2013	09:20	PR Newswire (Canada)	IIROC Trading Halt - GAP	TSXV:GAP	Pharmagap Inc.
06/05/2013	09:20	PR Newswire (Canada)	Suspension de la négociation par l'OCRCVM - GAP	TSXV:GAP	Pharmagap Inc.
06/02/2013	11:00	PR Newswire (Canada)	PharmaGap Receives Notice of Pending Transfer to NEX Exchange	TSXV:GAP	Pharmagap Inc.
04/02/2013	14:11	PR Newswire (Canada)	L’OCRCVM permet la reprise de la négociation - GAP	TSXV:GAP	Pharmagap Inc.
04/02/2013	14:11	PR Newswire (Canada)	IIROC Trading Resumption - GAP	TSXV:GAP	Pharmagap Inc.
04/02/2013	13:32	PR Newswire (Canada)	PharmaGap Provides Update on Status	TSXV:GAP	Pharmagap Inc.
02/08/2012	08:03	PR Newswire (Canada)	PharmaGap Shareholders Approve License to Clinical Value Corporation at Annual General Meeting	TSXV:GAP	Pharmagap Inc.
05/07/2012	09:00	PR Newswire (Canada)	PharmaGap Receives Independent Value Opinion and Support of Independent Committee for Proposed License to Clinical Value Corpor	TSXV:GAP	Pharmagap Inc.
05/06/2012	09:30	PR Newswire (Canada)	PharmaGap Updates Lead Drug Status and Potential Sale	TSXV:GAP	Pharmagap Inc.
24/05/2012	09:30	PR Newswire (Canada)	PharmaGap announces conditional approval to license its lead drug and related intellectual property	TSXV:GAP	Pharmagap Inc.
20/01/2012	18:19	Marketwired Canada	PharmaGap Completes $231,000 Private Placement	TSXV:GAP	Pharmagap Inc.
11/01/2012	18:21	Marketwired Canada	PharmaGap Completes $70,774 Private Placement	TSXV:GAP	Pharmagap Inc.
21/12/2011	10:00	Marketwired Canada	PharmaGap Completes In Vivo Study Protocol in Ovarian Cancer	TSXV:GAP	Pharmagap Inc.
05/12/2011	10:00	Marketwired Canada	PharmaGap Completes $634,210 Private Placement	TSXV:GAP	Pharmagap Inc.
28/11/2011	18:48	Marketwired	PharmaGap Completes Initial Closing of Private Placement	TSXV:GAP	Pharmagap Inc.
25/11/2011	11:00	Marketwired	PharmaGap Liposomal Formulations Achieve Key Milestones for Clinical Trials	TSXV:GAP	Pharmagap Inc.
15/11/2011	11:00	Marketwired	PharmaGap Announces Start of Definitive Animal Efficacy Study Required to Proceed to Clinical Trials	TSXV:GAP	Pharmagap Inc.
27/10/2011	10:00	Marketwired	PharmaGap Sets Time for in Vivo Tests	TSXV:GAP	Pharmagap Inc.
24/10/2011	10:00	Marketwired	PharmaGap Chooses Ovarian Cancer as Target for First Clinical Trials	TSXV:GAP	Pharmagap Inc.
21/10/2011	18:00	Marketwired	PharmaGap Completes Placement of Equity Units	TSXV:GAP	Pharmagap Inc.
19/10/2011	10:00	Marketwired	PharmaGap Completes Manufacturer Site Audits Required for Clinical Trial Submission	TSXV:GAP	Pharmagap Inc.
03/10/2011	09:38	Marketwired	PharmaGap Files Provisional Patent Application for Liposomal Formulations of GAP-107B8	TSXV:GAP	Pharmagap Inc.
30/09/2011	11:00	Marketwired	PharmaGap to Host Investor Conference Call	TSXV:GAP	Pharmagap Inc.
29/09/2011	09:43	Marketwired	PharmaGap Adds to Patent Portfolio For GAP-107B8 Cancer Drug; Expands Claims	TSXV:GAP	Pharmagap Inc.
22/09/2011	09:44	Marketwired	PharmaGap Completes Initial Close of Private Placement	TSXV:GAP	Pharmagap Inc.
12/09/2011	08:27	Marketwired	PharmaGap Announces Successful Completion of Liposomal Development With Significantly Improved Potency of Cancer Drug	TSXV:GAP	Pharmagap Inc.
17/08/2011	17:30	Marketwired	PharmaGap Completes Debt Conversion Transaction	TSXV:GAP	Pharmagap Inc.
04/08/2011	09:00	Marketwired	PharmaGap Completes $496,405 Private Placement	TSXV:GAP	Pharmagap Inc.